Related Experiment Video
Updated: Feb 13, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
An updated systematic review and meta-analysis of early outcomes after left atrial appendage occlusion
Charan Yerasi1, Mohamad Lazkani2, Prathik Kolluru3
1St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
Insights
Left atrial appendage occlusion (LAAO) is a safe and effective stroke prevention method for non-valvular atrial fibrillation (NVAF) patients. This meta-analysis confirms LAAO
Area of Science:
- Cardiology
- Interventional Cardiology
- Stroke Prevention
Background:
- Left atrial appendage occlusion (LAAO) offers a promising alternative for stroke prevention in patients with non-valvular atrial fibrillation (NVAF).
- Existing studies on early LAAO outcomes present variable results, necessitating a comprehensive summary.
Purpose of the Study:
- To conduct an updated meta-analysis summarizing the early outcomes of Left Atrial Appendage Occlusion (LAAO).
Main Methods:
- A systematic search of Medline/PubMed, Ovid Journals, Clinical Trials, Abstract Meetings, and Cochrane databases was performed.
- The search covered literature published from January 1, 1999, to November 30, 2016.
Main Results:
- The meta-analysis included 49 studies with 12,415 patients, with a median age of 73.5 years. Successful LAAO implantation was achieved in 96.3% of patients.
- Pooled outcomes included all-cause mortality at 0.28%, all-cause stroke at 0.31%, major bleeding at 1.71%, and pericardial effusion at 3.25%.
- Sub-analysis of randomized trials showed LAAO devices had lower mortality compared to warfarin, with similar bleeding risks.
Conclusions:
- Left atrial appendage occlusion (LAAO) is demonstrated to be a safe and effective strategy for stroke prevention in patients diagnosed with non-valvular atrial fibrillation (NVAF).
Background:
Left atrial appendage occlusion (LAAO) is a promising intervention for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). Early outcomes following LAAO have been published in many studies with variable results.
Objective:
This updated meta-analysis aims to provide a summary of the early outcomes of LAAO.
Methods:
Medline/Pubmed, Ovid Journals, Clinical trials, Abstract meetings, Cochrane databases were searched from January 1st, 1999 to November 30th, 2016.
Results:
This meta-analysis included 49 studies involving 12 415 patients. The median age was 73.5 years (IQR 72-75 years) and 43% were males. Hypertension and diabetes were present in 36% and 15% of the population, respectively. There was a prior history of stroke and congestive heart failure in 14% and 18% of the population, respectively. The median CHADS2 score was 2.9 (IQR 2.6-3.3) and the median HASBLED score was 3.3 (IQR 3-4). LAAO implantation was successful in 96.3% of patients (95.40-97.08, I2 = 76.1%). The pooled proportion of all-cause mortality was 0.28% (0.19-0.38, I2 = 0%). The pooled proportion of all-cause stroke was 0.31% (0.22-0.42, I2 = 9.4%), major bleeding requiring transfusion was 1.71% (1.13-2.41, I2 = 73.2%), and pericardial effusion was 3.25% (2.46-4.14, I2 = 79%). Sub analysis of randomized clinical trials comparing LAAO devices to warfarin showed lower mortality (P = 0.03) with similar bleeding risk (P = 0.20) with LAAO.
Conclusions:
This meta-analysis concludes that LAAO occlusion is a safe and effective stroke prevention strategy in patients with NVAF.
Related Concept Videos
Surface Appendages of Archaea
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Predicting Reaction Outcomes
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups

